News | November 14, 2021
Alarming rise in diabetes amongst children and adolescents in India
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
Key takeaways of recent quarter & conference call highlights
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
The company claims that its Empagliflozin tablets are the most affordable in India
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
Subscribe To Our Newsletter & Stay Updated
